Re: Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.
Su
Yi-Chang
YC
Lin
Jui-Shan
JS
Lee
Ming-Ta Michael
MT
Li
Tsai-Chung
TC
Lee
Shen-Ming
SM
D017677:Age Distribution; D000367:Age Factors; D034341:Aristolochic Acids / Q000008:administration & dosage* / Q000009:adverse effects*; D002273:Carcinogens; D016022:Case-Control Studies; D015986:Confounding Factors, Epidemiologic; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D016015:Logistic Models; D015999:Multivariate Analysis; D012107:Research Design; D012307:Risk Factors; D017678:Sex Distribution; D013624:Taiwan / Q000453:epidemiology; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced / Q000453:epidemiology; D014571:Urologic Neoplasms / Q000139:chemically induced* / Q000453:epidemiology*
D034341:Aristolochic Acids; D002273:Carcinogens; D004365:Drugs, Chinese Herbal